---
title: "Polygenic Risk Contribution to Non-Communicable Disease Burden and Healthcare Use in Taiwan"
id: "medrxiv-21-burden-of-non-communicable-diseases-attributable-to-polygenic-risk-and-its"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-burden-of-non-communicable-diseases-attributable-to-polygenic-risk-and-its"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.07.26365010v1?rss=1"
published_at: "2026-10-09T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Polygenic Risk Contribution to Non-Communicable Disease Burden and Healthcare Use in Taiwan
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-burden-of-non-communicable-diseases-attributable-to-polygenic-risk-and-its
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.07.26365010v1?rss=1)
- **Published At:** 2026-10-09T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study quantified the share of non-communicable disease (NCD) burden in Taiwan attributable to **polygenic risk scores (PRS)** using linked Taiwan Biobank and National Health Insurance Research Database data (N ≈ 140,000). - The authors evaluated 42 high-burden NCDs and defined elevated genetic risk (PRS_e) as the top 10% of PRS distribution. - Associations between elevated PRS and incident disease were estimated with Cox proportional hazards models; results were translated into population attributable fractions (PAFs) and disability-adjusted life years (DALYs) using Taiwan-specific Global Burden of Disease 2023 estimates. - Strongest relative associations for PRS_e were observed for **atrial fibrillation** (HR 3.56) and **gout** (HR 2.41), which produced PAFs of about 20% and 12% respectively. - At the population level, the largest PRS-attributable DALYs were for **type 2 diabetes (T2D)**, intracranial hemorrhage (ICH), and lung cancer; at the individual level, PRS_e corresponded to estimated loss of healthy life-years (e.g., 1.50 years for T2D, 0.57 years for ICH), with larger losses for top 1% PRS. - The polygenic attributable burden was generally greater in men than in women for the conditions examined. - For some diseases, the PRS_e-associated PAFs and DALYs exceeded those attributed to individual modifiable risk factors such as smoking and alcohol use (specific diseases not itemized beyond examples reported). - An integrated PRS (iPRS) in the top decile was associated with higher healthcare utilization: 23.9% more hospital days, 19.1% more inpatient visits, and 9.6% more outpatient visits. - The study links genetic liability to measurable population and individual-level burden, suggesting implications for integrating genetic risk into prevention and health planning in Taiwan. - The article is a preprint and has not been peer reviewed; ethical approvals and participant consent were obtained and reported, and data are available on request from the authors.
## Clinical Analysis & Structured Key Points
Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan | medRxiv Skip to main content Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan View ORCID Profile Mu-Yi Shih , Yi-Syuan Ke , Xue-Yong Chang , Ling-Hua Wang , Yen-Chen Anne Feng doi: https://doi.org/10.64898/2026.10.07.26365010 Mu-Yi Shih Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mu-Yi Shih Yi-Syuan Ke Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xue-Yong Chang Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ling-Hua Wang Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yen-Chen Anne Feng Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: ajfeng{at}ntu.edu.tw Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background Non-communicable diseases (NCDs) impose substantial population burden. Their polygenic architecture informs early risk stratification through polygenic risk scores (PRS). Previous studies reported elevated-PRS burden comparable to some modifiable risk factors (MRFs), yet evidence remains confined to European populations. We quantified the PRS-attributable NCD burden in Taiwan. Methods Linking Taiwan Biobank and National Health Insurance Research Database (N = 140K), we analyzed 42 high-burden NCDs. Elevated genetic risk (PRSe; top 10%) was assessed using Cox models. We estimated population attributable fractions (PAFs) and disability-adjusted life years (DALYs) using Taiwan-specific estimates from Global Burden of Disease 2023, and examined associations between an integrated PRS (iPRS) and healthcare utilization. Findings Strongest PRSe associations occurred for atrial fibrillation (AFib; HR = 3.56 [95% CI: 3.23-3.92]) and gout (2.41 [2.33-2.49]), yielding PAFs of 20% and 12%, respectively, while population-level attributable DALYs were largest for type 2 diabetes (T2D), intracranial hemorrhage (ICH), and lung cancer. At the individual level, PRS_e corresponded to 1.50 [1.42-1.57] healthy life-years lost for T2D and 0.57 [0.40-0.76] for ICH, approaching 2.4 years for the top 1% PRS. Polygenic attributable burden was overall greater in men. For several diseases, PRS_e-associated PAF and DALYs exceeded those of individual MRFs (e.g., smoking, alcohol use). Top-decile iPRS was linked to 23.9% (15.0-33.6%) more hospital days, 19.1% (13.2-25.3%) more inpatient visits, and 9.6% (6.9-12.4%) more outpatient visits. Interpretation Polygenic risk accounts for a measurable—and for several diseases, MRF-comparable—share of NCD burden in Taiwan, providing a quantitative foundation for integrating genetic liability into preventive care and health planning. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Access to the TWB data for this study was approved by the Ethics and Governance Council (EGC) of Taiwan Biobank (approval number: TWBR11211-02). The use of TWB and its linkage to the National Health Insurance Database (NHIRD) were approved by the Institutional Review Board of National Taiwan University Hospital (202308103RINB). The collection of TWB data was approved by its EGC and by the Department of Health and Welfare, Taiwan (Wei-Shu-I-Tzu No. 1010267471). TWB obtained informed consent from all participants for the research use of collected data. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Funder Information Declared National Taiwan University Academic Research-Career Development Project , NTU-115L7813 Yushan Young Fellow Program, Ministry of Education (TW) , MOE-111-YSFAG-0003-001-P1 Higher Education Sprout Project, Ministry of Education (TW) , NTU-115L900402 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted October 09, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan Mu-Yi Shih , Yi-Syuan Ke , Xue-Yong Chang , Ling-Hua Wang , Yen-Chen Anne Feng medRxiv 2026.10.07.26365010; doi: https://doi.org/10.64898/2026.10.07.26365010 Share This Article: Copy Citation Tools Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan Mu-Yi Shih , Yi-Syuan Ke , Xue-Yong Chang , Ling-Hua Wang , Yen-Chen Anne Feng medRxiv 2026.10.07.26365010; doi: https://doi.org/10.64898/2026.10.07.26365010 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (626) Allergy and Immunology (914) Anesthesia (341) Cardiovascular Medicine (4893) Dentistry and Oral Medicine (486) Dermatology (421) Emergency Medicine (662) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1649) Epidemiology (16086) Forensic Medicine (35) Gastroenterology (1221) Genetic and Genomic Medicine (7137) Geriatric Medicine (740) Health Economics (1077) Health Informatics (5149) Health Policy (1448) Health Systems and Quality Improvement (1798) Hematology (593) HIV/AIDS (1358) Infectious Diseases (except HIV/AIDS) (16378) Intensive Care and Critical Care Medicine (1185) Medical Education (682) Medical Ethics (156) Nephrology (730) Neurology (7414) Nursing (371) Nutrition (1105) Obstetrics and Gynecology (1268) Occupational and Environmental Health (1015) Oncology (3668) Ophthalmology (1072) Orthopedics (399) Otolaryngology (460) Pain Medicine (485) Palliative Medicine (142) Pathology (713) Pediatrics (1824) Pharmacology and Therapeutics (741) Primary Care Research (777) Psychiatry and Clinical Psychology (6011) Public and Global Health (9856) Radiology and Imaging (2470) Rehabilitation Medicine and Physical Therapy (1484) Respiratory Medicine (1257) Rheumatology (653) Sexual and Reproductive Health (788) Sports Medicine (589) Surgery (788) Toxicology (107) Transplantation (311) Urology (299)
## Related Clinical Research

- [Prevalence, risk factors, and renoprotective treatment gaps in chronic kidney disease among tertia](https://medichelpline.com/clinical-feed/bmj-open-9-prevalence-risk-factors-and-renoprotective-treatment-of-chronic-kidney-disease.md)
- [Dietary PUFA Intake, Sleep Patterns, and Lung Cancer Risk: Case-Control Findings from Southwest Ch](https://medichelpline.com/clinical-feed/plos-one-23-associations-of-dietary-polyunsaturated-fatty-acids-and-sleep-patterns-with.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Pope Leo XIV Diagnosed with Lung Adenocarcinoma: Key Insights](https://medichelpline.com/clinical-feed/medical-news-today-0-pope-leo-lung-cancer-diagnosis-what-to-know-about-lung-adenocarcinoma.md)
- [Rising stroke incidence in adults under 55 despite overall declines in the US](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rates-are-falling-overall-but-rising-among-adults-under-55.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.